- Choice of Capecitabine or S1 in Combination with Oxaliplatin based on Thymidine Phosphorylase and Dihydropyrimidine Dehydrogenase Expression Status in Patients with Advanced Gastric Cancer
-
Xu R, He X, Wufuli R, Su Y, Ma L, Chen R, Han Z, Wang F, Liu J
- KMID: 2466029
- J Gastric Cancer.
- 2019 Dec;19(4):408-416.
- doi: 10.5230/jgc.2019.19.e40
PURPOSE: To study the efficacy of capecitabine or S-1 plus oxaliplatin (CAPOX or SOX) for treating thymidine phosphorylase (TP)- or dihydropyrimidine dehydrogenase (DPD)-positive advanced gastric cancer. MATERIALS AND METHODS: Eighty-six patients... -
- CITED
-
- Close
- SHARE
-
- Close
